A citation-based method for searching scientific literature

Rui Mao, Mohamed S Hussein, Yukai He. Expert Rev Mol Med 2022
Times Cited: 3







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


CAR-T design: Elements and their synergistic function.
Jayapriya Jayaraman, Michael P Mellody, Andrew J Hou, Ruchi P Desai, Audrey W Fung, An Huynh Thuy Pham, Yvonne Y Chen, Weian Zhao. EBioMedicine 2020
76
66

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.
Stephan A Grupp, Michael Kalos, David Barrett, Richard Aplenc, David L Porter, Susan R Rheingold, David T Teachey, Anne Chew, Bernd Hauck, J Fraser Wright,[...]. N Engl J Med 2013
66

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.
Sara Ghorashian, Anne Marijn Kramer, Shimobi Onuoha, Gary Wright, Jack Bartram, Rachel Richardson, Sarah J Albon, Joan Casanovas-Company, Fernanda Castro, Bilyana Popova,[...]. Nat Med 2019
243
66

Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia.
Hanren Dai, Zhiqiang Wu, Hejin Jia, Chuan Tong, Yelei Guo, Dongdong Ti, Xiao Han, Yang Liu, Wenying Zhang, Chunmeng Wang,[...]. J Hematol Oncol 2020
117
33

Cancer immunoediting and resistance to T cell-based immunotherapy.
Jake S O'Donnell, Michele W L Teng, Mark J Smyth. Nat Rev Clin Oncol 2019
625
33

Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential.
Linlin Ma, Min Zhu, Junwei Gai, Guanghui Li, Qing Chang, Peng Qiao, Longlong Cao, Wanqing Chen, Siyuan Zhang, Yakun Wan. J Nanobiotechnology 2020
39
33

Pembrolizumab (Keytruda).
Gerry Kwok, Thomas C C Yau, Joanne W Chiu, Eric Tse, Yok-Lam Kwong. Hum Vaccin Immunother 2016
143
33

Bispecific antibodies in cancer immunotherapy.
Christoph Rader. Curr Opin Biotechnol 2020
35
33

Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8+ T cell responses.
Anthony E Zamora, Jeremy Chase Crawford, E Kaitlynn Allen, Xi-Zhi J Guo, Jesse Bakke, Robert A Carter, Hossam A Abdelsamed, Ardiana Moustaki, Yongjin Li, Ti-Cheng Chang,[...]. Sci Transl Med 2019
51
33

Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches.
Ji-Yoon Noh, Huiyun Seo, Jungwoon Lee, Haiyoung Jung. Int J Mol Sci 2020
13
33

Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia.
Natalia Colomar-Carando, Laurent Gauthier, Pietro Merli, Fabrizio Loiacono, Paolo Canevali, Michela Falco, Federica Galaverna, Benjamin Rossi, Frédéric Bosco, Mélody Caratini,[...]. Cancer Immunol Res 2022
6
33

Macrophages: sentinels and regulators of the immune system.
Lars Franken, Marzena Schiwon, Christian Kurts. Cell Microbiol 2016
89
33

Chimeric antigen receptor T cells for sustained remissions in leukemia.
Shannon L Maude, Noelle Frey, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey,[...]. N Engl J Med 2014
33

Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells.
Nathan Singh, Noelle V Frey, Boris Engels, David M Barrett, Olga Shestova, Pranali Ravikumar, Katherine D Cummins, Yong Gu Lee, Raymone Pajarillo, Inkook Chun,[...]. Nat Med 2021
29
33

Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo.
Michael C Milone, Jonathan D Fish, Carmine Carpenito, Richard G Carroll, Gwendolyn K Binder, David Teachey, Minu Samanta, Mehdi Lakhal, Brian Gloss, Gwenn Danet-Desnoyers,[...]. Mol Ther 2009
778
33

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
Shannon L Maude, Theodore W Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R Verneris, Heather E Stefanski, Gary D Myers,[...]. N Engl J Med 2018
33


Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
33

Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective.
Yu-Chi Chen, Wei Shi, Jia-Jie Shi, Jin-Jian Lu. J Cancer Res Clin Oncol 2022
8
33

Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia.
Bianca D Santomasso, Jae H Park, Darin Salloum, Isabelle Riviere, Jessica Flynn, Elena Mead, Elizabeth Halton, Xiuyan Wang, Brigitte Senechal, Terence Purdon,[...]. Cancer Discov 2018
403
33

Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22.
Haiying Qin, Sneha Ramakrishna, Sang Nguyen, Thomas J Fountaine, Anusha Ponduri, Maryalice Stetler-Stevenson, Constance M Yuan, Waleed Haso, Jack F Shern, Nirali N Shah,[...]. Mol Ther Oncolytics 2018
136
33

Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.
Mahmoud R Gaballa, Pinaki Banerjee, Denái R Milton, Xianli Jiang, Christina Ganesh, Sajad Khazal, Vandana Nandivada, Sanjida Islam, Mecit Kaplan, May Daher,[...]. Blood 2022
8
33

Cytotoxic CD8+ T cells in cancer and cancer immunotherapy.
Hans Raskov, Adile Orhan, Jan Pravsgaard Christensen, Ismail Gögenur. Br J Cancer 2021
190
33


Leukemia-induced dysfunctional TIM-3+CD4+ bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients.
Franziska Blaeschke, Semjon Willier, Dana Stenger, Mareike Lepenies, Martin A Horstmann, Gabriele Escherich, Martin Zimmermann, Francisca Rojas Ringeling, Stefan Canzar, Theresa Kaeuferle,[...]. Leukemia 2020
22
33

KTE-X19 efficacious in adults with B-ALL.
David Killock. Nat Rev Clin Oncol 2021
2
50

Natural killer cell-based strategies for immunotherapy of cancer.
Ondřej Vaněk, Barbora Kalousková, Celeste Abreu, Shiva Nejadebrahim, Ondřej Skořepa. Adv Protein Chem Struct Biol 2022
4
33

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.
Daniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, Yongzhi K Cui, Cindy Delbrook, Steven A Feldman, Terry J Fry, Rimas Orentas, Marianna Sabatino, Nirali N Shah,[...]. Lancet 2015
33

CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis.
Jeannette Fischer, Claudia Paret, Khalifa El Malki, Francesca Alt, Arthur Wingerter, Marie A Neu, Bettina Kron, Alexandra Russo, Nadine Lehmann, Lea Roth,[...]. J Immunother 2017
120
33

Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers.
Giuliana Beneduce, Antonia De Matteo, Pio Stellato, Anna M Testi, Nicoletta Bertorello, Antonella Colombini, Maria C Putti, Carmelo Rizzari, Simone Cesaro, Monica Cellini,[...]. Cancers (Basel) 2022
5
33

Assessment of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia: A Multicenter Study From Turkey.
Özlem Tüfekçi, Melike Sezgin Evim, Adalet Meral Güneş, Tiraje Celkan, Deniz Yilmaz Karapinar, Zühre Kaya, Birsen Baysal, Birol Baytan, Ülker Koçak, Şebnem Yilmaz,[...]. J Pediatr Hematol Oncol 2022
3
33

Acute Lymphoblastic Leukemia in Children.
Stephen P Hunger, Charles G Mullighan. N Engl J Med 2015
951
33

Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16.
Sima Jeha, Deqing Pei, John Choi, Cheng Cheng, John T Sandlund, Elaine Coustan-Smith, Dario Campana, Hiroto Inaba, Jeffrey E Rubnitz, Raul C Ribeiro,[...]. J Clin Oncol 2019
103
33

Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.
Anna Candoni, Mario Tiribelli, Eleonora Toffoletti, Daniela Cilloni, Alexia Chiarvesio, Angela Michelutti, Erica Simeone, Corrado Pipan, Giuseppe Saglio, Renato Fanin. Eur J Haematol 2009
72
33

A safe and potent anti-CD19 CAR T cell therapy.
Zhitao Ying, Xue F Huang, Xiaoyu Xiang, Yanling Liu, Xi Kang, Yuqin Song, Xiaokai Guo, Hanzhi Liu, Ning Ding, Tingting Zhang,[...]. Nat Med 2019
203
33

Blinatumomab, a Bispecific T-cell Engager (BiTE(®)) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications.
Min Zhu, Benjamin Wu, Christian Brandl, Jessica Johnson, Andreas Wolf, Andrew Chow, Sameer Doshi. Clin Pharmacokinet 2016
103
33

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT.
Hannah Kinoshita, Kenneth R Cooke, Melanie Grant, Maja Stanojevic, C Russell Cruz, Michael Keller, Maria Fernanda Fortiz, Fahmida Hoq, Haili Lang, A John Barrett,[...]. Blood Adv 2022
2
50

Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.
Xiaotu Ma, Yu Liu, Yanling Liu, Ludmil B Alexandrov, Michael N Edmonson, Charles Gawad, Xin Zhou, Yongjin Li, Michael C Rusch, John Easton,[...]. Nature 2018
402
33

CAR-NK cells for cancer immunotherapy: from bench to bedside.
Leisheng Zhang, Yuan Meng, Xiaoming Feng, Zhongchao Han. Biomark Res 2022
10
33

A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release.
Yiyang Xu, Zhiyuan Yang, Lucas H Horan, Pengbo Zhang, Lianxing Liu, Bryan Zimdahl, Shon Green, Jingwei Lu, Javier F Morales, David M Barrett,[...]. Cell Discov 2018
47
33


Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
Sara Raponi, Maria Stefania De Propris, Stefania Intoppa, Maria Laura Milani, Antonella Vitale, Loredana Elia, Omar Perbellini, Giovanni Pizzolo, Robin Foá, Anna Guarini. Leuk Lymphoma 2011
154
33

NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease.
Erin M Sullivan, Sima Jeha, Guolian Kang, Cheng Cheng, Barbara Rooney, Martha Holladay, Rafijul Bari, Sarah Schell, MaCal Tuggle, Ching-Hon Pui,[...]. Clin Cancer Res 2014
31
33


Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding.
Robyn J Puro, Myriam N Bouchlaka, Ronald R Hiebsch, Benjamin J Capoccia, Michael J Donio, Pamela T Manning, William A Frazier, Robert W Karr, Daniel S Pereira. Mol Cancer Ther 2020
40
33

CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report.
Yao Sun, Yongfeng Su, Yizhi Wang, Na Liu, Yuhang Li, Jianlin Chen, Zhuoqing Qiao, Jingwen Niu, Jiangwei Hu, Bin Zhang,[...]. Front Immunol 2021
5
33

Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies.
Florian Kast, Christian Klein, Pablo Umaña, Alena Gros, Stephan Gasser. Oncoimmunology 2021
5
33

Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL.
Nirali N Shah, Daniel W Lee, Bonnie Yates, Constance M Yuan, Haneen Shalabi, Staci Martin, Pamela L Wolters, Seth M Steinberg, Eva H Baker, Cindy P Delbrook,[...]. J Clin Oncol 2021
76
33

Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.
Yuan-Fang Liu, Bai-Yan Wang, Wei-Na Zhang, Jin-Yan Huang, Ben-Shang Li, Ming Zhang, Lu Jiang, Jian-Feng Li, Ming-Jie Wang, Yu-Jun Dai,[...]. EBioMedicine 2016
178
33

CD19: a biomarker for B cell development, lymphoma diagnosis and therapy.
Kemeng Wang, Guoqing Wei, Delong Liu. Exp Hematol Oncol 2012
255
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.